Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies (Q44190546)

30 November 2017

Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies (English)

1 reference

30 November 2017

13

Anthony S Fauci

1 reference

30 November 2017

Peter Schuck

9

0 references

Tae-Wook Chun

4

object named as

Tae-Wook Chun

1 reference

30 November 2017

2

Claudia Cicala

1 reference

30 November 2017

1

James Arthos

1 reference

30 November 2017

5

Charles Dela Cruz

1 reference

30 November 2017

12

Margery A Chaikin

1 reference

30 November 2017

6

Douglas B Hanback

1 reference

30 November 2017

3

Tavis D Steenbeke

1 reference

30 November 2017

Prateeti Khazanie

7

1 reference

30 November 2017

Daniel Nam

8

1 reference

30 November 2017

Sara M Selig

10

1 reference

30 November 2017

Donald Van Ryk

11

1 reference

30 November 2017

language of work or name

English

0 references

publication date

22 January 2002

1 reference

Journal of Biological Chemistry

30 November 2017

1 reference

30 November 2017

277

1 reference

30 November 2017

11456-11464

1 reference

30 November 2017

13

1 reference

Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

30 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

HIV infection is blocked in vitro by recombinant soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Designing CD4 immunoadhesins for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Enhancement of SIV infection with soluble receptor molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

HIV requires multiple gp120 molecules for CD4-mediated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Energetics of the HIV gp120-CD4 binding reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Crystal structure of an HIV-binding recombinant fragment of human CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Identification of the residues in human CD4 critical for the binding of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Direct sedimentation analysis of interference optical data in analytical ultracentrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

The organization of the envelope projections on the surface of HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

gp120: Biologic aspects of structural features

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M111191200

21 January 2018

Identifiers

DOI

10.1074/JBC.M111191200

1 reference

30 November 2017

1 reference